Simplex Trading
LMNL

Simplex Trading’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Simplex Trading’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-170
Closed -$1K – 11720
2021
Q4 		$1K Sell
170
-1,350
-89% -$20.2K ﹤0.01% 10298
2021
Q3 		$59K Buy
1,520
+10
+0.7% +$288 ﹤0.01% 7324
2021
Q2 		$58K Buy
+1,510
New +$65.8K ﹤0.01% 7470

Other funds holding LMNL

National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Simplex Trading's LMNL Position: Q4 2022 in Review

Simplex Trading sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q4 2022, closing a stake of 7 shares.

Simplex Trading first reported a position in LMNL in Q2 2021 and held it in 6 quarters. The position peaked at $10K in Q3 2021. 14 funds tracked by Wall St. Rank hold LMNL as of Q4 2022.

  • Simplex Trading reported no remaining Liminal BioSciences Inc. Common Shares position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 7 Liminal BioSciences Inc. Common Shares shares in Q4 2022.
  • Simplex Trading first reported a position in Liminal BioSciences Inc. Common Shares in Q2 2021 and held it in 6 quarters.
  • Simplex Trading's Liminal BioSciences Inc. Common Shares position peaked at $10K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.